Related references
Note: Only part of the references are listed.Polymorphisms in the dopamine transporter gene are associated with visual hallucinations and levodopa equivalent dose in Brazilians with Parkinson's disease
Artur F. Schumacher-Schuh et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
N-Methyl-D-Aspartate Antagonists in Levodopa Induced Dyskinesia: A Meta-Analysis
Behzad Elahi et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2012)
Scaffold protein Homer 1: Implications for neurological diseases
Peng Luo et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
DRD2 haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson's disease patients
Mariana Rieck et al.
PHARMACOGENOMICS (2012)
Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias
Imtiaz Ahmed et al.
BRAIN (2011)
A 12-Year Population-Based Study of Psychosis in Parkinson Disease
Elin B. Forsaa et al.
ARCHIVES OF NEUROLOGY (2010)
Assessing Individual Interethnic Admixture and Population Substructure Using a 48-Insertion-Deletion (INSEL) Ancestry-Informative Marker (AIM) Panel
Ney P. C. Santos et al.
HUMAN MUTATION (2010)
Epidemiology of psychosis in Parkinson's disease
Gilles Fenelon et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap
Paolo Calabresi et al.
LANCET NEUROLOGY (2010)
Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease
Claire L. Tomlinson et al.
MOVEMENT DISORDERS (2010)
Motor Complications in Patients Form the German Competence Network on Parkinson's Disease and the DRD3 Ser9Gly Polymorphism
Sebastian Paus et al.
MOVEMENT DISORDERS (2009)
HOMER1 Promoter Analysis in Parkinson's Disease: Association Study with Psychotic Symptoms
Vincenzo De Luca et al.
NEUROPSYCHOBIOLOGY (2009)
Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data
Frank Dudbridge
HUMAN HEREDITY (2008)
The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications
Monika Bialecka et al.
PHARMACOGENETICS AND GENOMICS (2008)
The dopamine D1 receptor agonist, but not the D2 receptor agonist, induces gene expression of Homer 1a in rat striatum and nucleus accumbens
Hidetaka Yamada et al.
BRAIN RESEARCH (2007)
Deep brain stimulation in a rat model modulates TH, CaMKIIa and Homer1 gene expression
Jeannette Henning et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Factors associated with the development of motor fluctuations and dyskinesias in Parkinson disease
Robert A. Hauser et al.
ARCHIVES OF NEUROLOGY (2006)
Epidemiology of Parkinson's disease
Lonneke M. L. de Lau et al.
LANCET NEUROLOGY (2006)
Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-Dopa-induced behavioral sensitization in dyskinetic rats
V Sgambato-Faure et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease -: An exploratory study
M Zappia et al.
ARCHIVES OF NEUROLOGY (2005)
Haploview: analysis and visualization of LD and haplotype maps
JC Barrett et al.
BIOINFORMATICS (2005)
Modulation of synaptic signalling complexes by Homer proteins
U Thomas
JOURNAL OF NEUROCHEMISTRY (2002)
Prospective longitudinal assessment of hallucinations in Parkinson's disease
CG Goetz et al.
NEUROLOGY (2001)
Prospective study of hallucinations and delusions in Parkinson's disease
S Holroyd et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature
JE Ahlskog et al.
MOVEMENT DISORDERS (2001)
Share Paper
